Pharma Mar
PHM.MC
#5570
Rank
A$2.09 B
Marketcap
A$121.39
Share price
-1.31%
Change (1 day)
-22.92%
Change (1 year)

Half-year Reports

Thumbnail Pharma Mar Half-year Report 2026-h1

Half-year Report 2026-h1

Language: English

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2026-h1

Half-year Report 2026-h1

Language: Spanish

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2025-h1

Half-year Report 2025-h1

Language: Spanish

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2024-h1

Half-year Report 2024-h1

Language: Spanish

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2024-h1

Half-year Report 2024-h1

Language: English

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2023-h1

Half-year Report 2023-h1

Language: English

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2023-h1

Half-year Report 2023-h1

Language: Spanish

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2022-h1

Half-year Report 2022-h1

Language: English

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2022-h1

Half-year Report 2022-h1

Language: Spanish

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2021-h1

Half-year Report 2021-h1

Language: Spanish

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2021-h1

Half-year Report 2021-h1

Language: English

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2020-h1

Half-year Report 2020-h1

Language: Spanish

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2019-h1

Half-year Report 2019-h1

Language: Spanish

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2019-h1

Half-year Report 2019-h1

Language: English

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2018-h1

Half-year Report 2018-h1

Language: English

View Half-year Report
Thumbnail Pharma Mar Half-year Report 2018-h1

Half-year Report 2018-h1

Language: Spanish

View Half-year Report